Cardiovascular Drugs — MCQs

Cardiovascular Drugs Indian Medical PG Practice Questions and MCQs

Question 901: Which of the following is an AT1 receptor blocker?

A. Spironolactone
B. Losartan (Correct Answer)
C. Captopril
D. None of the above

Explanation: **Explanation:** **Losartan (Option B)** is the correct answer. It belongs to the class of drugs known as **Angiotensin II Receptor Blockers (ARBs)**. These drugs act by selectively blocking the binding of Angiotensin II to the **AT1 receptor**, which is responsible for the majority of the physiological effects of Angiotensin II, including vasoconstriction, aldosterone release, and sympathetic activation. By blocking this receptor, ARBs effectively lower blood pressure and reduce cardiac remodeling. **Analysis of Incorrect Options:** * **Spironolactone (Option A):** This is a **Mineralocorticoid Receptor Antagonist (MRA)** or potassium-sparing diuretic. It works by blocking the action of aldosterone in the distal renal tubules, not the AT1 receptor. * **Captopril (Option C):** This is an **ACE Inhibitor (ACEI)**. It works by inhibiting the Angiotensin-Converting Enzyme, thereby preventing the conversion of Angiotensin I to Angiotensin II. While it reduces Angiotensin II levels, it does not block the receptor itself. **High-Yield Clinical Pearls for NEET-PG:** * **The "Sartan" Suffix:** All ARBs end in "-sartan" (e.g., Valsartan, Telmisartan, Irbesartan). * **Dry Cough:** Unlike ACE inhibitors, ARBs do not inhibit the breakdown of bradykinin. Therefore, they **do not cause the dry cough** commonly associated with drugs like Captopril. * **Teratogenicity:** Both ACEIs and ARBs are strictly **contraindicated in pregnancy** as they can cause fetal renal anomalies (fetopathy). * **Uricosuric Effect:** Losartan is unique among ARBs because it also inhibits the URAT1 transporter, increasing uric acid excretion, making it beneficial for hypertensive patients with **gout**.

Question 902: Why should a patient on verapamil not be given a beta-blocker?

A. Conduction block (Correct Answer)
B. Bronchospasm
C. Neurogenic shock
D. Anaphylaxis

Explanation: **Explanation:** The combination of **Verapamil** (a non-dihydropyridine calcium channel blocker) and **Beta-blockers** is contraindicated because both drugs exert potent negative inotropic, negative chronotropic, and negative dromotropic effects. 1. **Why Conduction Block is Correct:** Both drugs act on the Sinoatrial (SA) and Atrioventricular (AV) nodes. Verapamil blocks L-type calcium channels, while beta-blockers inhibit sympathetic stimulation. When used together, their synergistic effect significantly slows AV conduction and depresses myocardial contractility. This can lead to severe **bradycardia, high-grade AV block, or even asystole.** 2. **Why other options are incorrect:** * **Bronchospasm:** While beta-blockers (especially non-selective ones like Propranolol) can cause bronchospasm, Verapamil does not exacerbate this effect; in fact, calcium channel blockers are generally safe in asthmatics. * **Neurogenic Shock:** This is caused by a loss of sympathetic tone (usually due to spinal cord injury). While the drug combination causes hypotension, it does not trigger the specific pathophysiology of neurogenic shock. * **Anaphylaxis:** This is a Type I hypersensitivity reaction. Neither drug is specifically known to trigger anaphylaxis when combined. **High-Yield Clinical Pearls for NEET-PG:** * **Dihydropyridines (e.g., Amlodipine):** These can be safely combined with beta-blockers because they primarily cause peripheral vasodilation and do not significantly depress the AV node. * **Drug of Choice:** Verapamil is the drug of choice for **Prophylaxis of PSVT**, but it must never be given intravenously to a patient already on oral beta-blockers. * **Antidote:** In cases of severe toxicity/blockade from this combination, **Intravenous Calcium** or **Glucagon** may be used to increase heart rate and contractility.

Question 903: Which of the following is an Angiotensin II receptor antagonist?

A. Perindopril
B. Enalapril
C. Benazepril
D. Losartan (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. Losartan** **1. Why Losartan is Correct:** Losartan belongs to the class of drugs known as **Angiotensin II Receptor Blockers (ARBs)**. These drugs act by selectively blocking the binding of Angiotensin II to the **AT₁ receptor**. By antagonizing this receptor, ARBs prevent the potent vasoconstriction, aldosterone release, and sympathetic activation typically mediated by Angiotensin II. Unlike ACE inhibitors, ARBs do not inhibit the breakdown of bradykinin, which significantly reduces the incidence of dry cough and angioedema. **2. Why the Other Options are Incorrect:** * **A, B, and C (Perindopril, Enalapril, Benazepril):** These drugs belong to the **ACE Inhibitor (ACEI)** class. They work by inhibiting the Angiotensin-Converting Enzyme, preventing the conversion of Angiotensin I to Angiotensin II. A key suffix to remember for NEET-PG is that drugs ending in **"-pril"** are ACE inhibitors, whereas those ending in **"-sartan"** are ARBs. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **First-pass metabolism:** Losartan undergoes significant first-pass metabolism to form an **active metabolite (EXP-3174)**, which is more potent and long-acting than the parent drug. * **Uricosuric Effect:** Losartan is unique among ARBs because it inhibits the URAT1 transporter, increasing uric acid excretion. This makes it a preferred choice for hypertensive patients with **gout**. * **Contraindications:** Both ACEIs and ARBs are strictly **contraindicated in pregnancy** (teratogenic; cause fetal renal dysgenesis) and in patients with **bilateral renal artery stenosis**. * **Side Effects:** Hyperkalemia is a common side effect for both classes; monitoring serum potassium is essential.

Question 904: In a patient with poor glycemic control, hypertriglyceridemia, and low HDL, which of the following drug regimens would be best to manage dyslipidemia without the risk of myositis as a side effect?

A. Fibric acid derivatives
B. Nicotinic acid (Correct Answer)
C. Atorvastatin
D. Simvastatin

Explanation: **Explanation:** The patient presents with **diabetic dyslipidemia**, characterized by hypertriglyceridemia and low HDL levels [4]. **1. Why Nicotinic Acid (Niacin) is correct:** Nicotinic acid is the most potent agent for increasing **HDL levels** (by 15-35%) and is highly effective at lowering triglycerides [3]. Unlike statins and fibrates, nicotinic acid is not primarily associated with **myositis** or rhabdomyolysis when used as monotherapy. It works by inhibiting adipose tissue lipolysis and reducing hepatic VLDL synthesis. **2. Why the other options are incorrect:** * **Fibric acid derivatives (Fibrates):** While they are the first-line treatment for isolated hypertriglyceridemia, they carry a significant risk of **myopathy and myositis**, especially in patients with renal impairment or when combined with other drugs [2]. * **Atorvastatin & Simvastatin (Statins):** These are the gold standard for lowering LDL. However, **myalgia and myositis** are their most well-known dose-dependent side effects. In a patient specifically concerned about myositis risk, statins are less ideal than Niacin for managing the TG/HDL axis. **3. NEET-PG High-Yield Pearls:** * **Side Effects of Niacin:** The most common side effect is **cutaneous flushing** (mediated by Prostaglandin $D_2$), which can be prevented by taking **Aspirin** 30 minutes prior. It can also cause **hyperuricemia** (precipitating gout) and **hyperglycemia** (worsening glycemic control—a key caution in diabetics) [1]. * **Myositis Risk:** The risk of myositis increases exponentially when **Statins are combined with Fibrates** (especially Gemfibrozil) because fibrates inhibit the glucuronidation of statins, increasing their plasma levels [2]. * **Drug of Choice:** For isolated high TG, Fibrates are DOC; for high LDL, Statins are DOC; for increasing HDL, Niacin is most effective [3].

Question 905: All of the following drugs are used in the management of acute Myocardial infarction except?

A. Tissue plasminogen activator
B. Intravenous beta blockers
C. Acetylsalicylic acid
D. Calcium channel blockers (Correct Answer)

Explanation: In the management of **Acute Myocardial Infarction (AMI)**, the primary goals are to restore coronary blood flow, reduce myocardial oxygen demand, and prevent further thrombus formation [1]. **Why Calcium Channel Blockers (CCBs) are the correct answer:** CCBs (like Nifedipine or Verapamil) are **not** used in the routine management of AMI. In fact, short-acting dihydropyridines (Nifedipine) are **contraindicated** because they cause reflex tachycardia and peripheral vasodilation, which can worsen myocardial ischemia and increase mortality [2]. While CCBs may be used for secondary prevention in patients who cannot tolerate Beta-blockers, they have no role in the acute phase. **Explanation of other options:** * **Tissue Plasminogen Activator (tPA):** A fibrinolytic agent used for reperfusion in ST-elevation MI (STEMI) when primary PCI is not immediately available. It dissolves the obstructing clot [1]. * **Intravenous Beta-blockers:** These reduce heart rate, blood pressure, and myocardial contractility, thereby decreasing oxygen demand. They help limit infarct size and reduce the risk of tachyarrhythmias. * **Acetylsalicylic acid (Aspirin):** An antiplatelet agent that is mandatory in AMI. It inhibits thromboxane A2 synthesis, preventing further platelet aggregation and thrombus expansion [3]. **High-Yield Clinical Pearls for NEET-PG:** * **MONA** is the classic mnemonic for AMI: **M**orphine, **O**xygen, **N**itroglycerin, and **A**spirin. * **Beta-blockers** are contraindicated in AMI if the patient has signs of heart failure, low output state, or heart block. * **ACE Inhibitors** should be started within 24 hours of AMI to prevent ventricular remodeling. * **Lidocaine** was previously used for prophylaxis against arrhythmias in MI but is no longer recommended routinely.

Question 906: Which of the following drugs is used for the prophylaxis of migraine but not for angina pectoris?

A. Verapamil
B. Diltiazem
C. Flunarizine (Correct Answer)
D. Amlodipine

Explanation: **Explanation:** The correct answer is **Flunarizine**. **1. Why Flunarizine is correct:** Flunarizine is a **non-selective calcium channel blocker (CCB)** that also possesses antihistaminic, anti-dopaminergic, and anti-serotonergic properties. Unlike the CCBs used in cardiology, Flunarizine primarily acts on the central nervous system. It prevents intracellular calcium overload in neurons, which stabilizes neuronal activity and inhibits the "cortical spreading depression" associated with migraine pathogenesis. However, it has **no significant effect on systemic vascular resistance or myocardial oxygen demand**, making it ineffective for the treatment or prophylaxis of angina pectoris. **2. Why the other options are incorrect:** * **Verapamil (Phenylalkylamine):** This is a cardioselective CCB. It is used for angina (by reducing heart rate and contractility) and is also a first-line drug for the prophylaxis of **cluster headaches** and occasionally migraine. * **Diltiazem (Benzothiazepine):** This drug has intermediate effects on both the heart and blood vessels. It is a standard treatment for angina pectoris but is not typically used for migraine prophylaxis. * **Amlodipine (Dihydropyridine):** This is a potent peripheral vasodilator used extensively for chronic stable angina and hypertension. It has no established role in migraine prophylaxis. **3. High-Yield Clinical Pearls for NEET-PG:** * **Side Effects of Flunarizine:** Due to its anti-dopaminergic activity, it can cause **extrapyramidal symptoms (drug-induced Parkinsonism)** and significant weight gain/sedation. It should be avoided in patients with a history of depression or Parkinson’s disease. * **Drug of Choice:** While Flunarizine is used for migraine prophylaxis, **Propranolol** (a beta-blocker) remains the first-line agent. * **Verapamil Unique Use:** It is the prophylactic drug of choice for **Cluster Headache**, not just migraine.

Question 907: Digoxin acts by inhibiting which of the following?

A. Na+/K+ ATPase (Correct Answer)
B. Calcium channel
C. Potassium channel
D. Adenyl cyclase

Explanation: **Mechanism of Action** Digoxin, a cardiac glycoside, exerts its primary effect by reversibly inhibiting the **Na+/K+ ATPase pump** (specifically the alpha subunit) on the myocardial cell membrane. 1. **Inhibition of the pump** leads to an increase in intracellular Sodium ($Na^+$). 2. This high intracellular $Na^+$ reduces the concentration gradient required for the **$Na^+/Ca^{2+}$ exchanger** (NCX) to function. 3. Consequently, $Ca^{2+}$ extrusion from the cell is decreased, leading to increased intracellular Calcium ($Ca^{2+}$) storage in the sarcoplasmic reticulum. 4. During subsequent depolarizations, more $Ca^{2+}$ is released, resulting in a **positive inotropic effect** (increased force of contraction). **Analysis of Incorrect Options** * **B. Calcium channel:** Digoxin does not block calcium channels; in fact, it indirectly increases intracellular calcium levels. Calcium channel blockers (like Verapamil) are a different class of drugs used for hypertension and arrhythmias. * **C. Potassium channel:** While Digoxin affects potassium (it competes with $K^+$ for the binding site on the ATPase pump), it does not directly inhibit potassium channels. Class III anti-arrhythmics (like Amiodarone) act here. * **D. Adenyl cyclase:** This enzyme is involved in the cAMP pathway. Drugs like Dobutamine (Beta-agonists) act via this pathway, not Digoxin. **High-Yield Clinical Pearls for NEET-PG** * **Electrolyte Interaction:** Hypokalemia predisposes to Digoxin toxicity because $K^+$ and Digoxin compete for the same binding site on the Na+/K+ ATPase pump. * **ECG Changes:** The classic sign of Digoxin effect is the "Reverse Tick" sign or "Sagging" ST-segment depression (Salvador Dali mustache appearance). * **Vagal Effect:** Digoxin also increases vagal tone, making it useful for rate control in Atrial Fibrillation by slowing conduction through the AV node. * **Toxicity:** The most common initial symptom of toxicity is anorexia/nausea; the most characteristic visual disturbance is Xanthopsia (yellow-green vision).

Question 908: Which of the following is a true statement regarding Atrioventricular block with atrial tachycardia?

A. Seen in Wolff-Parkinson-White syndrome
B. Is a complication of pacemaker insertion
C. Can occur in a normal person occasionally
D. Seen in Digitalis toxicity with potassium depletion (Correct Answer)

Explanation: **Explanation:** The combination of **Atrial Tachycardia (AT) with Atrioventricular (AV) block** is considered the most characteristic (pathognomonic) arrhythmia of **Digitalis toxicity**, especially when associated with **hypokalemia (potassium depletion)**. **Why the correct answer is right:** Digoxin has a dual effect on cardiac tissue: 1. **Increased Automaticity:** It increases intracellular calcium, leading to delayed after-depolarizations (DADs). This triggers rapid firing in the atria, causing Atrial Tachycardia. 2. **Decreased Conduction:** It increases vagal tone and directly inhibits the AV node, leading to a prolonged PR interval or AV block. While most tachyarrhythmias show 1:1 conduction, Digitalis is unique because it simultaneously stimulates the atria while depressing the AV node, resulting in the classic "PAT with block." Hypokalemia exacerbates this by increasing digoxin binding to the Na+/K+ ATPase pump. **Why the other options are wrong:** * **Option A:** WPW syndrome is characterized by an accessory pathway (Bundle of Kent) which typically leads to tachyarrhythmias *without* AV block (e.g., AVRT). * **Option B:** Pacemaker complications usually involve lead displacement, infection, or "pacemaker syndrome," but not specifically AT with AV block. * **Option C:** While isolated PACs or first-degree blocks can occur in healthy individuals, the specific combination of AT with AV block always signifies underlying pathology or drug toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Most common arrhythmia in Digoxin toxicity:** Ventricular Bigeminy. * **Most characteristic/specific arrhythmia:** Atrial Tachycardia with AV block. * **Electrolyte triggers:** Hypokalemia, Hypercalcemia, and Hypomagnesemia all predispose to toxicity. * **Treatment of choice:** Digibind (Digoxin-specific Fab fragments). Avoid DC cardioversion as it may precipitate ventricular fibrillation.

Question 909: Magnesium sulfate potentiates the hypotensive action of which drug?

A. Methyldopa
B. Nifedipine (Correct Answer)
C. Enalapril
D. Hydralazine

Explanation: **Explanation:** The correct answer is **Nifedipine**. **Mechanism of Interaction:** Magnesium sulfate ($MgSO_4$) acts as a physiological calcium channel blocker. It inhibits the entry of calcium into cells and antagonizes calcium-dependent processes. **Nifedipine** is a dihydropyridine Calcium Channel Blocker (CCB). When used concurrently, they exert a synergistic effect on vascular smooth muscle relaxation. This potentiation can lead to profound vasodilation, resulting in severe, unpredictable hypotension and potentially neuromuscular blockade. This interaction is clinically significant in the management of pre-eclampsia and eclampsia, where both drugs may be considered. **Analysis of Incorrect Options:** * **A. Methyldopa:** A centrally acting $\alpha_2$ agonist. While used in pregnancy-induced hypertension (PIH), it does not share a common pathway with magnesium’s calcium-antagonizing properties. * **C. Enalapril:** An ACE inhibitor. Its hypotensive effect is mediated through the renin-angiotensin-aldosterone system (RAAS). It is also contraindicated in pregnancy due to teratogenicity (renal dysgenesis). * **D. Hydralazine:** A direct-acting vasodilator. While it causes hypotension, its mechanism (primarily involving $K^+$ channels or $IP_3$ inhibition) is not directly potentiated by magnesium in the same synergistic manner as CCBs. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** $MgSO_4$ is the drug of choice for the treatment and prophylaxis of seizures in **Eclampsia**. * **Toxicity Sign:** The first sign of Magnesium toxicity is the **loss of deep tendon reflexes (patellar reflex)** (at 7–10 mEq/L). * **Antidote:** The specific antidote for Magnesium toxicity is **10% Calcium Gluconate** (10 mL IV over 10 mins). * **Monitoring:** Always monitor urine output, respiratory rate, and knee jerk when a patient is on $MgSO_4$.

Question 910: Which of the following statements is NOT true about ACE inhibitors?

A. Contraindicated in asthma
B. Lacks postural hypotension
C. Decreases potassium concentration (Correct Answer)
D. Does not affect quality of life

Explanation: **Explanation:** **1. Why Option C is the correct answer (The False Statement):** ACE inhibitors (ACEIs) inhibit the conversion of Angiotensin I to Angiotensin II. Since Angiotensin II is a potent stimulator of **Aldosterone** secretion from the adrenal cortex, its inhibition leads to decreased aldosterone levels. Aldosterone normally promotes sodium reabsorption and potassium excretion in the distal tubules. Therefore, a reduction in aldosterone results in **potassium retention**, leading to **Hyperkalemia**, not a decrease in potassium concentration. **2. Analysis of Incorrect Options:** * **Option A (Contraindicated in asthma):** This is a **true** statement regarding Beta-blockers, but **not** for ACE inhibitors. ACEIs do not cause bronchospasm and are safe to use in asthmatic patients (though they may cause a dry cough due to bradykinin accumulation). * **Option B (Lacks postural hypotension):** This is **true**. Unlike many other antihypertensives (like alpha-blockers), ACEIs do not interfere with sympathetic reflexes; thus, they rarely cause postural hypotension. * **Option C (Does not affect quality of life):** This is **true**. ACEIs are "well-tolerated" drugs. They do not cause sedation, depression, or sexual dysfunction, which are common side effects of other antihypertensives that negatively impact the quality of life. **Clinical Pearls for NEET-PG:** * **Teratogenicity:** ACEIs are strictly contraindicated in pregnancy (cause fetal renal dysgenesis). * **Bilateral Renal Artery Stenosis:** ACEIs can precipitate acute renal failure in these patients. * **Drug of Choice:** ACEIs are the first-line treatment for hypertension in patients with **Diabetes Mellitus** (due to nephroprotective effects) and **Heart Failure**. * **Side Effect Mnemonic (CAPTOPRIL):** **C**ough (dry), **A**ngioedema, **P**roteinuria, **T**aste changes, **O**thostatic hypotension (rare), **P**regnancy contraindication, **R**enal artery stenosis contraindication, **I**ncreased potassium (**Hyperkalemia**), **L**eukopenia.

Practice by Chapter

Antihypertensive Agents

Practice Questions

Drugs for Heart Failure

Practice Questions

Antiarrhythmic Drugs

Practice Questions

Antianginal Agents

Practice Questions

Lipid-Lowering Drugs

Practice Questions

Anticoagulants and Antiplatelet Drugs

Practice Questions

Thrombolytic Agents

Practice Questions

Drugs Used in Pulmonary Hypertension

Practice Questions

Drugs Used in Shock

Practice Questions

Cardiovascular Effects of Non-Cardiovascular Drugs

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free